pmc logo image
Extended adjuvant hormonal therapy with exemestane has no detrimental effect on the lipid profile of postmenopausal breast cancer patients: final results of the ATENA lipid substudy
Christos Markopoulos, Urania Dafni, John Misitzis, Vasilios Zobolas, Evagelos Tzoracoleftherakis, Dimitrios Koukouras, Grigorios Xepapadakis, John Papadiamantis, Basileios Venizelos, Zoh Antonopoulou, Helen Gogas
Breast Cancer Res. 2009; 11(3): R35. Published online 2009 June 16. doi: 10.1186/bcr2320
PMCID:
PMC2716503
Abstract Full Text PDF–281K
 Is Cited by the Following 2 Articles in this Archive:
Exemestane in the Adjuvant Treatment of Breast Cancer in Postmenopausal Women
Muaiad Kittaneh, Stefan Glück
Breast Cancer (Auckl) 2011; 5: 209–226. Published online 2011 October 9. doi: 10.4137/BCBCR.S6234
PMCID:
PMC3201097
Abstract Full Text PDF–749K
Minimizing early relapse and maximizing treatment outcomes in hormone-sensitive postmenopausal breast cancer: efficacy review of AI trials
Christos J. Markopoulos
Cancer Metastasis Rev. 2010 December; 29(4): 581–594. Published online 2010 September 10. doi: 10.1007/s10555-010-9248-x
PMCID:
PMC2962795
Abstract Full Text PDF–344K
You are here: NCBI > Literature > PubMed Central
Write to the Help Desk